Critical assessment of the important residues involved in the dimerization and catalysis of MERS Coronavirus Main Protease

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Ho, Bo Lin ^a   Cheng, Shu Chun ^a   Shi, Lin ^a   Wang, Ting Yun ^a   Ho, Kuan I ^a   Chou, Chi Yuan ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS MAIN PROTEASE; UNCLASSIFIED DRUG; VIRUS ENZYME; PAPAIN; PEPTIDE HYDROLASE; VIRAL PROTEIN;

AREA UNDER THE CURVE; ARTICLE; CATALYSIS; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICAL ASSESSMENT; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DIMERIZATION; ENZYME ANALYSIS; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HELICAL DOMAIN III; ISOTHERMAL TITRATION CALORIMETRY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; STEADY STATE; STRUCTURE ACTIVITY RELATION; ULTRACENTRIFUGATION; WILD TYPE; CHEMISTRY; ENZYMOLOGY; METABOLISM; MOLECULAR MODEL; PROTEIN MULTIMERIZATION; SEQUENCE ANALYSIS; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MODELS, MOLECULAR; PAPAIN; PEPTIDE HYDROLASES; PROTEIN MULTIMERIZATION; SEQUENCE ANALYSIS, PROTEIN; VIRAL PROTEINS;

EID: 84961308110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144865     Document Type: Article

References (36)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. Epub 2012/10/19. doi: 10.1056/NEJMoa1211721 .
2. Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect. 2012; 65 (6):477-89. Epub 2012/10/18. doi: 10.1016/j.jinf.2012.10.002 .
3. Anderson LJ, Baric RS. Emerging human coronaviruses-disease potential and preparedness. N Engl J Med. 2012; 367(19):1850-2. Epub 2012/10/19. doi: 10.1056/NEJMe1212300 .
4. Eckerle I, Muller MA, Kallies S, Gotthardt DN, Drosten C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol J. 2013; 10:359. Epub 2013/12/25. doi: 10.1186/1743-422X-10-359
5. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013; 369(5):407-16. Epub 2013/06/21. doi: 10.1056/NEJMoa1306742 .
6. Reusken CB, Haagmans BL, Muller MA, Gutierrez C, Godeke GJ, Meyer B, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. Lancet Infect Dis. 2013; 13(10):859-66. Epub 2013/08/13. doi: 10.1016/S1473-3099(13) 70164-6 .
7. Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR, Schoeman MC, et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis. 2013; 19 (10):1697-9. doi: 10.3201/eid1910.130946
8. Drexler JF, Corman VM, Drosten C. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res. 2014; 101:45-56. doi: 10.1016/j.antiviral.2013.10.013 .
9. Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013; 503(7477):535-8. doi: 10.1038/nature12711 .
10. Kilianski A, Mielech AM, Deng X, Baker SC. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. J Virol. 2013; 87(21):11955-62. Epub 2013/08/30. doi: 10.1128/JVI.02105-13
11. Lin MH, Chuang SJ, Chen CC, Cheng SC, Cheng KW, Lin CH, et al. Structural and functional characterization of MERS coronavirus papain-like protease. J Biomed Sci. 2014; 21(1):54. Epub 2014/06/06. doi: 10.1186/1423-0127-21-54
12. Chou CY, Lai HY, Chen HY, Cheng SC, Cheng KW, Chou YW. Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease. Acta Crystallogr D Biol Crystallogr. 2014; 70(Pt 2):572-81. Epub 2014/02/18. doi: 10.1107/S1399004713031040 .
13. Cheng KW, Cheng SC, Chen WY, Lin MH, Chuang SJ, Cheng IH, et al. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res. 2015; 115:9-16. doi: 10.1016/j.antiviral.2014.12.011 .
14. Tomar S, Johnston ML, St John SE, Osswald HL, Nyalapatla PR, Paul LN, et al. Ligand-induced dimerization of MERS coronavirus nsp5 protease (3CLpro): implications for nsp5 regulation and the development of antivirals. J Biol Chem. 2015. doi: 10.1074/jbc.M115.651463 .
15. Needle D, Lountos GT, Waugh DS. Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity. Acta Crystallogr D Biol Crystallogr. 2015; 71 (Pt 5):1102-11. doi: 10.1107/S1399004715003521
16. Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A. 2003; 100 (23):13190-5. doi: 10.1073/pnas.1835675100
17. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003; 300(5626):1763-7. doi: 10.1126/science.1085658 .
18. Chou CY, Chang HC, Hsu WC, Lin TZ, Lin CH, Chang GG. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochemistry. 2004; 43(47):14958-70. doi: 10.1021/bi0490237 .
19. Hsu MF, Kuo CJ, Chang KT, Chang HC, Chou CC, Ko TP, et al. Mechanism of the maturation process of SARS-CoV 3CL protease. J Biol Chem. 2005; 280(35):31257-66. doi: 10.1074/jbc.M502577200 .
20. Xue X, Yu H, Yang H, Xue F, Wu Z, Shen W, et al. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J Virol. 2008; 82(5):2515-27. doi: 10.1128/JVI. 02114-07
21. Fan K, Wei P, Feng Q, Chen S, Huang C, Ma L, et al. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem. 2004; 279 (3):1637-42. doi: 10.1074/jbc.M310875200 .
22. Wu A, Wang Y, Zeng C, Huang X, Xu S, Su C, et al. Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus. Virus Res. 2015; 208:56-65. doi: 10.1016/j.virusres.2015.05.018 .
23. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26.
24. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Cryst. 2007; 40:658-74.
25. Wu CG, Cheng SC, Chen SC, Li JY, Fang YH, Chen YH, et al. Mechanism for controlling the monomerdimer conversion of SARS coronavirus main protease. Acta Crystallogr D Biol Crystallogr. 2013; 69(Pt 5):747-55. Epub 2013/05/02. doi: 10.1107/S0907444913001315 .
26. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. doi: 10.1107/S0907444910007493
27. Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):355-67. Epub 2011/04/05. doi: 10.1107/S0907444911001314
28. Cheng SC, Chang GG, Chou CY. Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease. Biophys J. 2010; 98(7):1327-36. doi: 10.1016/j.bpj.2009.12.4272
29. Hsieh YH, Chou CY. Structural and functional characterization of human apolipoprotein E 72-166 peptides in both aqueous and lipid environments. J Biomed Sci. 2011; 18:4. doi: 10.1186/1423-0127-18-4
30. Chou YW, Cheng SC, Lai HY, Chou CY. Differential domain structure stability of the severe acute respiratory syndrome coronavirus papain-like protease. Arch Biochem Biophys. 2012; 520(2):74-80. Epub 2012/03/07. doi: 10.1016/j.abb.2012.02.015 .
31. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J. 2000; 78:1606-19.
32. Schuck P. On the analysis of protein self-Association by sedimentation velocity analytical ultracentrifugation. Anal Biochem. 2003; 320(1):104-24. .
33. Chou CY, Hsieh YH, Chang GG. Applications of analytical ultracentrifugation to protein size-And-shape distribution and structure-And-function analyses. Methods. 2011; 54(1):76-82. doi: 10.1016/j.ymeth. 2010.11.002 .
34. Chou CY, Chien CH, Han YS, Prebanda MT, Hsieh HP, Turk B, et al. Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biochem Pharmacol. 2008; 75 (8):1601-9. Epub 2008/03/04. doi: 10.1016/j.bcp.2008.01.005 .
35. Zhang S, Zhong N, Xue F, Kang X, Ren X, Chen J, et al. Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-Active octamer of SARS-CoV main protease. Protein Cell. 2010; 1(4):371-83. doi: 10.1007/s13238-010-0044-8 .
36. Gouet P, Courcelle E, Stuart DI, Metoz F. ESPript: Analysis of multiple sequence alignments in Post-Script. Bioinformatics. 1999; 15(4):305-8.